Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a new resource entry for Cutaneous neuroendocrine carcinoma under the Genetic and Rare Diseases Information Center resources in the study page.
    Difference
    0.1%
    Check dated 2026-04-02T05:51:26.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Replaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the locations section.
    Difference
    0.0%
    Check dated 2026-03-26T03:11:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision tag v3.5.0 was added, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T19:52:15.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 removed. This is a minor UI/versioning update that does not alter study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:19.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, while the prior Revision: v3.4.1 and a government funding/operating status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:55:20.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center staying open, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.